Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
CURRICULUM VITAE
Name: Barbara S. Giesser, M.D.
Business Address: UCLA School of Medicine Reed Neurologic Research Center 710 Westwood Plaza Los Angeles, Ca. 90095 (310) 825-7313
Citizenship: USA
EDUCATION
1968-1972 University of Miami, Coral Gables, FL B.S. 1972-1974 University of Texas Graduate School of
Biomedical Sciences at Houston, Tx. M.S. (Virology)1974-1978 University of Texas Medical School, San Antonio M.D.
HOSPITAL TRAINING
1978-1979 Montefiore Hospital, Bronx, New York Medicine Intern 1979-1982 Bronx Municipal Hospital Center, Bronx, NY Neurology Resident 1982-1983 Albert Einstein College of Medicine, Bronx, NY Fellow, Neurology
LICENSURE
1979 New York 140361 (Active) 1984 New Jersey MA44787 (Inactive) 1992 Arizona 20709 (Inactive) 2002 California C 50803 (Active)
BOARD CERTIFICATION
1985 Diplomate (Neurology), American Board of Psychiatry & Neurology 1992 Certified, American Society of Neurorehabilitation; re-certified, 1997, 2002
PROFESSIONAL EXPERIENCE
10/12-present Professor of Clinical Neurology UCLA 7/07-9/12 Clinical Professor of Neurology, UCLA 9/02-present Medical Director, MS Achievement Center, UCLA 7/02-present Clinical Director, MS Program, UCLA 7/02-6/07 Associate Clinical Professor of Neurology, UCLA 4/98-6/02 Medical Director for Neurology, Arizona Telemedicine Program 2/93-6/02 Associate Professor of Clinical Neurology, AHSC, Tucson 12/91-6/95 Medical Director, Rehabilitation Institute of Tucson 1/92-1/93 Clinical Lecturer in Neurology, AHSC, Tucson 1988-1991 Consultant staff, Burke Rehabilitation Center Mamaroneck, New York
Page 1
ARGENTUM EX1003
Revised, March 16,2016
2
1985-1990 Medical Director, Bernard Gimbel MS Comprehensive Care Center, Holy Name Hospital, Teaneck, NJ
1983-1991 Assistant Professor of Neurology, Albert Einstein College of Medicine, Bronx NY 1982-1991 Attending Neurologist, Multiple Sclerosis Research
and Training Center, Albert Einstein College of Medicine 1982-1991 Attending Neurologist, Hospital of the Albert Einstein
College of Medicine 1981-1982 Staff physician, Headache Unit Montefiore Hospital,
Bronx, NY
PROFESSIONAL ACTIVITIES
Committee and Educational Service (David Geffen UCLA School of Medicine) 2003-pres. Member, GEC 2004- 2006 Member QA Committee 2004-2005 Neurology Clerkship Co-Director 2005- 2006 Neurology Clerkship Director 2005 Member, Psychiatry Clerkship Review Committee 2005 Dep’t. of Neurology Taxation Review Committee 2006-pres. Vice Chair for Clinical & Educational Affairs, Dep’t of Neurology 2007-2008 Neurology Clerkship Co- Director 2007-2008 SOM Clinical Education Task Force 2008-2011 Residency Selection Committee, DON 2008-2011 Residency Training Committee, DON 2008-pres Organizer & faculty, “Neurology for Psychiatrists” lecture series 2009-2011 Search Committees member, Neuromuscular, Epilepsy, Headache 2009-2010 COM Science of Learning Symposium, planning committee & panel member 2012-2015 DON Care Connect Committee 2013-pres Member, DON In-pt. Oversight Committee 2013-2015 DON Residency Selection Committee 2013-2015 DON Residency Training Committee 2012-2014 DON representative, FPG QI initiative 2014, 2015 Co Facilitator: Teaching Humanism at the Bedside 2014-pres Member, Clinical CAP Committee ( SOM)
Committee Service (University of Arizona Health Sciences Center {AHSC}) 1996-1997 Vice Chair, HCB Review Sub-Committee 1996-2000 COM Admissions Committee 1997-2002 Dep’t. of Neurology P&T Committee 1997-2002 Dep’t. of Neurology Resident Education Committee 1998-2002 COM Curriculum Committee 1999-2000 Chair, SBS Review Sub-committee 2000-2001 Dean’s Advisory Committee on Admissions 2000-2002 Chair, Electives Sub-Committee 2000-2001 Dean’s Committee on Women Faculty 2001-2002 Chair, HCB Review Sub-committee 2001-2002 Vice-Chair, COM Curriculum Committee
Page 2
Revised, March 16,2016
3
Community Service
1992-2000 Board of Directors, Desert SW Chapter, National MS Society 2002-2004 Professional Advisory Committee So. Cal. Chapter National MS Society 2003- 2015. Board of Directors, So. Cal Chapter, National MS Society 2003 Member, Strategic Long Term Planning Committee, So. Cal. Chapter, NMSS 2004-2006 Chair, Professional Advisory Committee, So. Cal. Chapter, NMSS 2016 Member, Healthcare Advisory Committee So Cal. Chapter NMSS Professional Societies 1985-1993 Active member, American Academy of Neurology 1987-1994 Active member, American Academy of Clinical Neurophysiology 1993- Fellow, American Academy of Neurology 2012- Fellow, American Neurological Association Professional Activities
1991 Chair, Scientific Session on Rehabilitation, 43rd Annual Meeting of the AAN (Boston) 1997 Member, Task Force on Gender Issues in Multiple Sclerosis. NMSS 1997 Principal author, “Compendium of Multiple Sclerosis Information, 2nd Edition.” NMSS 1997-1999 Counselor, AAN Section on Multiple Sclerosis. 1998-2000 Chair, Scientific Issues Committee, American Society of Neurorehabilitation 1999 Author, “Core Curriculum for MS” AAN Section on MS 1999-2003 Chair, Client Education Committee, National MS Society (New York) 1999- Advisory Panel, MS Women Neurologists Initiative 1999-2005 Member, AAN Undergraduate Education Subcommittee 1999- 2011 Chair, Education Committee, AAN Section on MS
1999-2003 Member, Executive Committee, Medical Advisory Board, NMSS (New York) 2000 Grant Reviewer, Texas Higher Education Coordinating Board, Biomedicine Panel 2002-pres Member, Selection Panel National MS Society Clinical Fellowship in MS 2003 Member, Clinical Expert Panel, MS Quality Indicators Project, National MS Society (NY) 2003- Invited Member, MS Forum 2003-2005 Member, Client Education Committee, National MS Society (New York) 2003-2009 Member, Professional Education Committee, National MS Society (New York) 2003- Member, Medical Advisory Board, National MS Society ( New York) 2004 Chair, Quintessentials module on Multiple Sclerosis (AAN)
2005-2007 Editor in Chief, Initiatives newsletter( Publication of the Women Neurologist’s MS Initiative)
2007-2008 Member, Neuroscience Question Writing Task Force, NMBE (Part ll) ( Philadelphia) 2009-2011 Chair, Professional Education Committee National MS Society ( New York) 2009 Delegate, AAN “Neurology on the Hill”( Washington D.C.) 2009 Member, NIH review panel 2012-2015 Member, NMSS Patient Management, Care and Rehabilitation peer review study section 2012 Member, NIH Expert review panel for PROMIS® 2012-2014 Chair, Client Education Committee National MS Society ( New York)
Page 3
Revised, March 16,2016
4
2014- NMSS Wellness Task Force, Co-Chair( Dallas November, 2014) 2014 AAN MS Quality Measures Development Work Group( Minneapolis) 2015 NMSS Public Policy Forum ( Washington DC, March 2015) 2015 Member, General Neurology Topic Work Group AAN( Minneapolis) 2016 Member, General Neurology Topic Work Group AAN( Minneapolis) 2016-2017 Chair, Clinical Fellowship Committee NMSS Editorial Service
1999 Ad Hoc Reviewer, Archives of Internal Medicine 2003 Editorial Board, MS Quarterly Report 2005 Ad Hoc Reviewer, J. Rehabilitation Research & Development 2006 Ad Hoc Reviewer, Neurology, Neurorehabilitation & Neural Repair 2008 Ad hoc reviewer, Archives of PM.&R, Continuum(AAN) 2010 Ad hoc reviewer, Int. J. of MS Care, Neurorehabilitation & Neural Repair 2011 Ad hoc reviewer, JRR&D, Neuropsychiatric Disease & Rx. 2013 Ad hoc reviewer, Exp Rev OB/Gyn, J. of Medical Internet Research, Neurology
Exp. Rev. Clin. Immunology 2014 Ad hoc reviewer, JRR&D, Neurorehabilitation. & Neural Repair 2015- Editorial board, Neurology Now ( AAN) 2015 Guest Editor, “Sex Differences in the Study of Neurological Illnesses” Behavioral
Neurology Vol 2015
AWARDS
1982 Leo Davidoff Society Award for Excellence in Housestaff Teaching (Albert Einstein Coll. Med)
1992 DOVE Award, Desert Southwest Chapter, National MS Society 1995 AHSC, Dean’s List Award for Excellence in Teaching in Clinical Sciences 1995 AHSC, Dean’s Teaching Scholar 1995 Community Education Volunteer of the Year, Desert Southwest Chapter
National MS Society 1996 Teacher of the Year, Neurology Department, AHSC 1997 Award for Outstanding Research in Medical Education, WGEA 1997 Virginia and Vernon R. Furrow Grant Award for Innovations in
Educational Technology
1998 Dedication Award, Desert Southwest Chapter, National MS Society 1997-2006 Who’s Who in the World 1997-2008 Who’s Who in Medicine & Healthcare 1998-2008 Who’s Who in America 2000 Dedication Award, Desert Southwest Chapter, National MS Society 2001 Dedication Award, Desert Southwest Chapter, National MS Society 2001 Volunteer Appreciation Award, Desert Southwest Chapter, National MS Society 2002, 2011 AB Baker Section (AAN) Teaching Recognition Certificate 2003 Sylvia Lawry Founder of the Year Award So. Cal. Chapter, National MS Society 2004 Hall of Fame Inductee National Multiple Sclerosis Society 2005, 2007, 2009, 2011,2013,2014,2015,2016 Best Doctors in America 2009 “Teaching Humanism at the Bedside” Award ( David Geffen UCLA School of Medicine)
Page 4
Revised, March 16,2016
5
2010 Serge & Yvette Dadone Award for Excellence in Clinical Teaching ( David Geffen UCLA SOM)
2012 Elected to American Neurological Association 2016 RRUCLAMC “Exceptional Physician” Award
GRANTS
1987-1988 National Multiple Sclerosis Society ($8,300) PI: Evoked Potentials &Cognition in MS
1989-1991 National Multiple Sclerosis Society ($287,000) PI: Longitudinal Study of Evoked
Potentials and Cognition in MS
1990-1991 Eastern Paralyzed Veterans Association ($33,000) PI: Use of the Levo-Chair in MS
1997-1998 National Multiple Sclerosis Society ($26,000) PI: Neurologic Status and the Menstrual
Cycle in MS
2003-2004 National Multiple Sclerosis Society ($44,000): PI: Locomotor Training Using Body Weight
Support on a Treadmill in Persons with MS
2006-2009 National Multiple Sclerosis Society ($602,689) PI: Robotic locomotor training in persons with
MS
2002-2008 National MS Society, Harry Weaver Junior Faculty Award, ($512,867) Co- I. “The Onset of Progressive MS: Structural and Functional Determinants (NL Sicotte, PI)
2005-2010 National Multiple Sclerosis Society ($825,000) Co-investigator (R. Voskuhl PI).
“A Collaborative MS Research Center Award: Neuroprotection in EAE/MS”
2007-2013 National MS Society, NIH($ 4,768,091) Co-Investigator(R. Voskuhl, PI)
A Combination Trial of Copaxone Plus Estriol in RRMS. 2007-2009 National MS Society ($392,350) Co-investigator: (NL Sicotte, PI)
Hippocampal volume loss in MS: Clinical consequences 2007-2010 National MS Society($487,973) Co-investigator: ( B. Vickrey, PI)
Development of Indicators for Multiple Sclerosis. 2009-2013 National MS Society($560,819) PI: “Exercise as a strategy to treat cognitive dysfunction in persons with MS”
2013-2014 National MS Society ($44,000) PI: Cooling strategies in persons with MS
2014-2015 AUPN ( $100,000) Co-PI( C.Flippen, PI): Educational grant: The NERVE
project: videotaping the resident neurologic examination
CLINICAL TRIALS
1998-1999 Site PI: A double blind, placebo controlled dose determination safety, tolerability
and efficacy study of intravenous Antegren in patients with MS during an acute attack.
1999-2001 Co-Investigator: The CORAL Study: A multinational, multicenter, randomized double blind, placebo controlled study to evaluate the effect of 2 doses of glatiramer acetate administered orally in R/R MS patients. 2002-2005 Co-investigator: (R Voskuhl, PI): Trial of Testosterone Treatment for Multiple Sclerosis 2006-2009 PI: Locomotor training in persons with Multiple Sclerosis
Page 5
Revised, March 16,2016
6
2007-2013 Co-investigator, Site PI ( R. Voskuhl PI)A multicenter, double blind, randomized, placebo controlled combination trial of Copaxone plus estriol in relapsing remitting MS 2011-2012 Co-investigator (R. Voskuhl, PI) Randomized, controlled combination trial of estriol to treat cognitive impairment in women with MS 2009-2014 PI: Exercise as a strategy to treat cognitive dysfunction in persons with MS 2013-2014 PI: Cooling strategies in persons with MS
LECTURES and PRESENTATIONS
Invited Presentations
1.“Evoked potentials as outcome measures.” Presented at the 7th Annual Meeting of the MS Consortium, Halifax, Nova Scotia, (June 1991). 2.“Event related potentials in MS patients: Neuropsychologic and MRI correlates.” Presented at the workshop on Neurobehavioral Dysfunction in MS, Bergamo, Italy, (June, 1992). 3.“Dysphagia in Multiple Sclerosis.” Presented at ASHA, San Antonio, Tx. (November 1992) 4.“Gender differences in Neurologic Autoimmune Disease.” Presented at the Healthy Women 2000 Conference, USPHS, Washington, D.C., (June 1996). 5.“Neurorehabilitation of MS” Neurology Grand Rounds, Univ. of Maryland, Baltimore( Feb. 2001) 6. “Update on MS” California Pharmacists Association Annual Meeting Anaheim, (March 2003) 7. Keynote Speaker, Annual MS Meeting, MS Society of Australia Melbourne( June, 2003) 8. Presentation, “Integrating Wellness into the Medical Model of MS Care” 22nd Annual Meeting of the CMSC Washington DC (May, 2007) 9. 18th annual Stanley Waterman Research Lecture:” Estriol & the promise of now: Emerging therapeutics for MS” Central NE Chapter, NMSS Newton, Mass. (March, 2008) 10.Presentation to PREP program pre-med students, (May, 2009) 11. “Robotic Rehabilitation Experience in MS” First International Transformational Technology in Rehabilitation Summit (Downey, CA. September, 2010) 12. Keynote Speaker, 2011 AAMC White Coat Ceremony, UCLA ( Los Angeles, Ca August 2011) 13. Keynote Speaker, NMSS Annual Research Symposium New York, (September 2011)
CME Course Faculty
1.Chair, “Neurology for Non-Neurologists” 2nd World Congress of Neurorehabilitation Toronto (April,1999) 2.Faculty,“Women’s Issues in MS” Univ. of So. Fla. Office of Continuing Education Santa Fe, NM (July 2000) 3. Faculty” Gender Issues in MS” AAN 53rd Annual Meeting Philadelphia, (May, 2001) 4. Faculty, “Fatigue & Spasticity in MS” Third Annual Current Topics in the Treatment of MS Univ. of So. Fla. Office of Continuing Education Asheville, NC (November, 2001) 5.Faculty,” Gender Issues in MS” ASNR Course: Integrating New Advances into the Medical and Rehabilitative Treatment of MS. Reno, Nevada (November, 2001) 6.Chair,” Integrating Wellness into MS Management” Los Angeles (March, 2003) 7.Director, “Practical Symptom Management in MS” Course at 55th annual meeting AAN, Honolulu (April 2003) 8.Co-chair, “Update on MS and Parkinson’s Disease” Los Angeles (September, 2003)
Page 6
Revised, March 16,2016
7
9.Chair, “Integrating Wellness into MS Management” Los Angeles, (March, 2004) 10.Faculty, Consortium of MS Centers “Multiple Sclerosis Preceptorship” Los Angeles (October, 2004) 11.Chair, “Integrating Wellness in MS Management” Los Angeles, (March 2005) 12.Faculty, “Update on Management of MS and Movement Disorders” Neurology Residents & Fellows Forum UCSD Dep’t. of Neurosciences ANA San Diego,Ca. (September,2005) 13.Chair, “Innovations in Managing Chronic Neurologic Disease” Los Angeles, (March 2006) 14.Faculty, “Advances in MS And Sleep Medicine” Dinner for UCLA DON Voluntary Faculty Los Angeles (April 2007) 15. Presentation, “Integrating Wellness into the medical model of MS Care” 22nd CMSC Annual meeting Washington DC ( May, 2007) 16.Speaker, Grand Rounds, “New Approaches to Multiple Sclerosis” Century City Medical Center Los Angeles (June, 2007) 17. Co-Chair,”Complimentary Approaches to Wellness in Chronic Neurologic Disease” Los Angeles, (October, 2007) 18.Faculty, “Optimizing Management of Neurological Disorders” Los Angeles, (Nov. 2007) 19.Co- Chair, “Neurology for Non-Neurologists” Los Angeles (March 2008) 20.Speaker, UNLV Dep’t. of Medicine Grand Rounds, “Update on MS” Las Vegas (April 2008) 21.Faculty, Family Practice Update:” Diagnosis & Treatment of MS” Los Angeles, (May,2008) 22.Co-Chair, “Neurology for Non-Neurologists” Los Angeles, (March 2009) 23.Neurology Grand Rounds, Cedars-Sinai Medical Center ”New Treatments for MS” Los Angeles, (May 2009) 24.Neuroscience Grand Rounds Harbor UCLA Medical Center” Symptom management in MS’ ( Nov.,2009) 25.Co Chair, “Complementary & Alternative Medicine in Neurology” UCLA Extension (May 2010) 26. Discussant, Grand Rounds: “CPC: Optic Neuritis” UCLA Dept’. of Neurology (Sept. 2010) 27. Speaker, Provident St. Joseph Medical Center Grand Rounds, ”Update on MS” (Burbank, May, 2011) 28. Speaker, Neuroscience Grand Rounds, Harbor UCLA: “Updates on MS” ( March 2012) 29. Faculty, “Updates on Multiple Sclerosis” UCLA DON Voluntary Faculty Dinner Los Angeles (April 2012) 30. Presentation, “Wellness models in MS” 27th Annual meeting of Consortium of MS Centers San Diego, Ca. ( June 2012) 31.Director, “Integrative Management of MS” course at 65th AAN Annual meeting ( San Diego, Ca. (March 2013) 32.Faculty, Ist Annual UCLA Review of Clinical Neurology: “Multiple Sclerosis” ( Los Angeles, September 2013) 33. Faculty, Current Strategies in the Diagnosis & Treatment of MS, “Therapeutic Applications of Exercise for Persons with MS” (Jersey City, NJ Sept. 2013) 34. Speaker, “Optimizing the use of DMD in MS” California Neurologic Society (Monterey,Ca. Oct.2013) 35. Grand Rounds Semel Neuropsychiatric Institute: “Comprehensive Management of Persons with MS ( Los Angeles February 2014) 36. Director, “Integrative Management of MS” course at 66th AAN Annual meeting ( Philadelphia, Pa. April, 2014) 37. Director, ”Gender Issues in MS” 29th CMSC Annual meeting(Dallas, May, 2014) 38. Co Chair, 2ndannual UCLA Review of Clinical Neurology ( Los Angeles,September 2014)
Page 7
Revised, March 16,2016
8
39. Faculty, “Current & emerging treatment options in MS” 10th annual Johns Hopkins MS Symposium (Sacramento, January 2015) 40. Director, “Symptom management in MS” 67 AAN annual meeting ( Wash.D.C, Apr.2015) 41. Co-Chair: 3rd Annual UCLA Review of Clinical Neurology ( Los Angeles, September,2015) 42. Faculty, “Symptom Management in MS” 68th AAN annual meeting( Vancouver, BC April 2016)
FACULTY/RESIDENT MENTOR
Dr. Callene Momtazee 2005-2006 Dr. Indu Subramanian 2008-2011 Dr. Leah Ngiemphieu 2008-2013 Dr. Lara Schrader 2010-2013 Dr. Justin Cheongsiatmoy 2011-2014 Dr. Matthew Tremblay 2012-2014 Dr. Marwa Kaisey 2013-2017 Dr. Nicholas Parziale 2014-2016 Dr. Katherine Podraza 2016-2017 Dr. Nasheed Jamal 2016- Other Teaching ( Geffen SOM) Neurology resident didactics ( MS lectures) 2003-present Third year clerkship lectures ( MS) 2003-2012 Faculty:” Doctoring” 2003 2004 Block 4 Neuroscience PBL facilitator, 2004, 2005, 2006 Faculty, Clinical Fundamentals 2006 Faculty, Clinical skills lab :1st year med students( 2008-2013) Mentor, Jennifer Danesh( 3rd yr medical student) Jan –May 2015 Casebook facilitator( medical student clerkship) June/July 2016 Mentor, PREP student ( July 2016)
BIBLIOGRAPHY
A.RESEARCH PAPERS-PEER REVIEWED
1.Kopchick J, Harless J, Giesser B, et al. (1981). Endodeoxyribonuclease activity associated
With Rauscher murine leukemia virus, Journal of Virology 37:274-278.
2. LaRocca N, Scheinberg L, Slater R, Giesser,B, Smith C, Traugott U, et al. (1984)
Field testing of a minimal record of disability in MS: the US and Canada. Acta Neurologica
Scandinavica Supplementum 101: 126-138
3.Giesser B, Kurtzberg D, Vaughan HG, Arezzo JC, Aisen M, Smith C, LaRocca N and
Scheinberg LC. (1987). Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of Multiple Sclerosis. Archives of Neurology, 44:281-294.
4.Novak GP, Wiznitzer M, Kurtzberg D, Giesser B, and Vaughan H.(1988). The utility of visual
Evoked potentials using hemifield stimulation and several check sizes in the evaluation of Suspected Multiple Sclerosis. Electroencephalography and Clinical Neurophysiology, 71:1-11
5. Scheinberg L, Smith C, Giesser B, Traugott U, Aisen M, LaRocca N et al. Efficacy & toxicity
of cyclosporine in chronic progressive MS: a randomized double blinded placebo controlled clinical trial. ( 1990) Ann. of Neurology 27(6) 591-605
Page 8
Revised, March 16,2016
9
6.Smith CR, LaRocca N, Giesser B, and Scheinberg LC. (1991). High dose oral baclofen:
Experience in patients with Multiple Sclerosis. Neurology, 41:1829-1830
7.Giesser B,Schroeder MM, LaRocca N, Kurtzberg D, Ritter W, Vaughan HG, Scheinberg L.
(1992)Endogenous event-related potentials as indices of dementia in Multiple Sclerosis patients
Electroencephalography and Clinical Neurophysiology, 82:320-329
8.Schroeder MM, Lipton RB, Ritter W, Giesser B, Vaughan HG. (1995) Event-related potential
correlates of early processing in normal aging. International Journal of Neuroscience, 80(1-
4):1-82.
9.Ratzker PK, Feldman J, Scheinberg L, LaRocca NG, Smith CR, Giesser B, Aisen M(1996)
Self assessment of neurologic impairment of MS. J. of Neurologic Rehab., 11:207-211
10.Kochler NK, Genain C, Giesser B, Hauser S. ( 2002) The human T cell response to
myelin Oligodendrocyte glycoprotein: A Multiple Sclerosis family based study. J. Of
Immunology 168 2-8
11.Coyle PK, Christie S, Fodor P, Fuchs K ,Giesser B, Gutierriez A, Lynn J, Weinstock-
Gutmann, B, Pardo L. (2004) Multiple Sclerosis gender issues: clinical practices of women neurologists. Multiple Sclerosis 10(5) 582-588
12.Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez Bresnahan M, Stam-
Moraga M, Chang P, Francis GS. ( 2005) Pregnancy outcomes during treatment with interferon beta 1a in patients with MS. Neurology 65(6) 802-806
13. Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S. (2007) Locomotor training
improves mobility in persons with MS: A pilot study. Multiple Sclerosis 13 (2) 224-231
14. Sicotte N, Giesser B,Tandon V, Klutch R,Steiner B, Drain A, Shattuck D, Hull L, Wang H,
Elashoff R, Swerdloff R, Voskuhl R. (2007) Potential neuroprotective effects of testosterone Treatment in relapsing remitting MS. Arch. Of Neurology 64 (5) 683-688
15.Sicotte NL, Kern K, Giesser B, Schultz A, Montag M, Vinters HV, Bookheimer SY.( 2007)
Hippocampal abnormalities in multiple sclerosis: imaging and histopathological findings. Multiple Sclerosis 13(Suppl 2):S14,
16. Cardinal KS, Wilson S, Giesser B, Drain AE, Sicotte NL. ( 2008) A longitudinal fMRI
study of the PASAT. Multiple Sclerosis, 14 465-471
17.Sicotte N,Kern K, Giesser B, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer
S. (2008) Regional hippocampal atrophy in MS. Brain 131( pt.4) 1134-1141
18. Hay, C, Strathmann C, Lieber E, Wick K, & Giesser B. (2008) Why patients go on line:
MS, the internet, and physician patient communication. The Neurologist 14(6) 374-81
19.Gold S, Chalifoux S, Giesser B, Voskuhl R. (2008) Immune modulation and increased
neurotrophic factor production in MS patients treated with testosterone. J. Neuroinflammation
5:32
20. Gold S, Kern K, O’Connor M-F, Montag M, Kim A, Yoo YS, Giesser B,and Sicotte N. (2010) Smaller Cornu Ammonis 2–3/Dentate Gyrus Volumes and Elevated Cortisol in Multiple Sclerosis Patients with Depressive Symptoms. Biol. Psych 68(6) 553-559 21. Cheng EM, Crandall CJ,. Bever C, Giesser B,
Haselkorn J, Hays R, Shekelle P,
Vickrey B. (2010) Quality Indicators for Multiple Sclerosis. Multiple Sclerosis 16 (8) 970-981
22. Sicotte, N, Kern K, Sarcona J, Montag M, Giesser B. (2011)Corpus callosal diffusivity
predicts motor impairment in relapsing-remitting multiple sclerosis: A TBSS and tractography Study Neuroimage 55(3) 1169-1177
23. Kern K, Ekstrom A, Suthana N, Giesser B, Montag M, Arshnanpali A, Bookheimer S,
Sicotte N. (2012) Fornix damage limits verbal memory functional compensation in MS.
Page 9
Revised, March 16,2016
10
Neuroimage Feb 1;59(3):2932-40.
24. Kurth F, Luders E, Sicotte NL, Gaser C, Giesser BS, Swerdloff RS, Montag MJ, Voskuhl RR, McKenzie-Graham AJ. (2014)Testosterone effects on gray matter density in men with multiple sclerosis: a voxel-based morphometry study. Neuroimage Clin. Mar 6;4:454-60. 25. Voskuhl, R, Wang, H, Wu, TJ, Sicotte N,Nakamura K, Kurthn F, Itoh N, Bardens J, Bernard J, Corboy J, Cross A, Dhib-Jalbut S, Ford, C, Frohman, E, Giesser B, et al. Estriol combined with glatiramer acetate for women with relapsing remitting MS: a randomized, placebo controlled phase 2 trial. (2015) The Lancet 26.Robert J. Fox , Christopher S. Coffey Merit E. Cudkowicz , Trevis Gleason Andrew Goodman ,Eric C. Klawiter , KazukoMatsuda, Michelle McGovern Robin Conwit , Robert Naismith ,Akshata Ashokkumar , Robert Bermel , Dixie Ecklund , Maxine Koepp, Jeffrey Long Sneha Natarajan ,Srividya Ramachandran , Thomai Skaramagas Brenda Thornell Jon Yankey , Mark Agius ,Khurram Bashir , Bruce Cohen Patricia Coyle Silvia Delgadon, Dana Dewitt Angela Flores, Barbara Giesser, et al. Design, rationale, and baseline characteristics of the randomized double-blindphase II clinical trial of ibudilast in progressive multiple sclerosis(2016). Cont. Clinical Trials 50 166-177
B. RESEARCH PAPERS-PEER REVIEWED (IN PRESS) NONE
C. RESEARCH PAPERS-PEER REVIEWED (SUBMITTED)
Giesser B, Herlihy E, Plummer D’Amato P, West M, Budovitch A, Pokras N, et al. Randomized
controlled trial of robotic locomotor training in persons with MS.( in revision) D. RESEARCH PAPERS-NON-PEER REVIEWED NONE E. RESEARCH PAPERS-NON-PEER REVIEWED (IN PRESS) NONE F. RESEARCH PAPERS-NON-PEER REVIEWED (SUBMITTED) NONE
CHAPTERS
1.Scheinberg LC, Kalb R, LaRocca N, Giesser B, Slater R and Poser C. The doctor-patient
relationship in Multiple Sclerosis. In: The Diagnosis of Multiple Sclerosis C Poser, L. Scheinberg, Eds. New York; Thieme-Stratton, Inc. pp 205-215 (1984).
2.Scheinberg LC, and Giesser B. Drug Therapy. In: Multiple Sclerosis: A Guide for Patients
and Families, 2nd Edition. L Scheinberg and N Holland, Eds. New York: Raven Press. pp. 53-66 (1987).
3.Simmons JQ and Giesser B. Treatment with diet ibid pp 67-78(1987).
4.Giesser B and Holtzer M. Wheelchairs, walkers, canes, and other aids. In: Orthotics in
Neurologic Rehabilitation Mindy Aisen, Ed. New York: Demos Press, pp 131-146 (1992)
5. Giesser, B. “Multiple Sclerosis” In: Current Diagnosis and Treatment of Women
Page 10
Revised, March 16,2016
11
Dawn Lemcke, Julie Pattison, Lorna Marshall, Rebecca Cowley, Eds. New York McGraw Hill pp.402-410 (2003)
6. Giesser,B. “Botulism” In: Lynn, DJ, Newton, HB, Rae-Grant AD, Eds. The 5-Minute
Neurology Consult Philadelphia, Pa. Lippincott, Williams & Wilkins pp.80-81(2004)
7. Giesser,B. “Trichinosis “ In: : Lynn, DJ, Newton, HB, Rae-Grant AD, Eds. The 5-Minute
Neurology Consult Philadelphia, Pa. Lippincott, Williams & Wilkins pp.424-425 (2004)
8. Birk, K & Giesser B “Fertility, Pregnancy & Childbirth” in: MS: A Guide for Families, 3rd Ed.
Rosalind Kalb, Ed. New York Demos Press, pp.81-92 ( 2006)
9. Giesser B . “Immunosuppressive & Novel Therapies” in: Primer on MS B. Giesser, Ed.
New York, Oxford University Press pp.349-368 ( 2011)
10. Voskuhl R, and Giesser B. “Gender & Reproductive Issues” in: Primer on MS B. Giesser,
Ed. New York, Oxford University Press pp.221-240 ( 2011)
11. Giesser, B. Diagnosis of MS. In: “Multiple Sclerosis” Neurologic Clinics Emmanuelle
Waubant, Ed. Philadelphia, W.B. Saunders pp.381-388 (2011)
12.Giesser B, Benedetto-Anazi M, Werner M. Fertility, pregnancy childbirth and gynecologic
care. In: MS: The questions you have the answers you need. Rosalind Kalb, Ed. New York Demos Health pp 269-282 (2011)
13. Giesser, B. “Trichinosis “ In: : Lynn, DJ, Newton, HB, Rae-Grant AD, Eds. The 5-Minute
Neurology Consult Philadelphia Lippincott, Williams & Wilkins (2011)
14. Momtazee C & Giesser B. “Sex-Determined Issues in Multiple Sclerosis” in Multiple
Sclerosis & Other CNS Demyelinating Diseases; pp67-76 Samkoff L & Goodman A, Eds. Wiley Blackwell (2014).
15.Voskuhl R & Giesser B. “Gender & Reproductive Issues” in: Primer on MS B. Giesser, Ed.
New York, Oxford University Press ( 2nd Ed.) pp259-282 (2016)
16. Giesser,B. “Relapses , immunosuppressive and novel therapies” in: Primer on MS
B. Giesser, Ed. New York, Oxford University Press ( 2nd Ed.) pp442-463 (2016)
CHAPTERS (IN PRESS)
NONE
BOOKS
1.Scheinberg LC, Giesser B and Schaumburg HH. Neurology Handbook, 2nd Edition. (1986).
New York: Medical Examination Publishing Co.
2.Giesser B, Aisen M and Scheinberg LC. Neurology Specialty Board Review Book, 3rd
Edition. (1986). New York: Elsevier Publishing.
3.Giesser B, Kanof P, Aisen M and Elkin R. Neurology Specialty Board Review Book, 4th
Edition. (1996). Connecticut: Appleton & Lange
4. Kalb R, Holland N, Giesser B. MS for Dummies (2007) Indianapolis: Wiley Publishing
5. Giesser,B. ( Ed.) Primer on MS (2011) New York: Oxford University Press
6. Kalb R, Giesser B, Costello K. MS for Dummies: Second edition (2012) Indianapolis: Wiley
Publishing
7. Thrower, B, Costello, K, Giesser B. Navigating Life with MS (2015) New York: Oxford
University Press
8.Giesser B(Ed.). Primer on MS ,Second Edition. (2016) New York: Oxford University Press
Page 11
Revised, March 16,2016
12
LETTERS TO THE EDITOR
Giesser B. How I learned to stop worrying and love DNA. NEJM. (1978)
Scheinberg LC & Giesser B. INH in MS. Neurology 34:134-135 ( 1984)
Giesser B. Primary Lateral Sclerosis. Arch. Neurol. 46(11) 1166-7 (1989)
REVIEWS
1.Giesser B. Landry-Guillain-Barre Syndrome. (1983). Medical Times III, 87-90.
2.Blaivas JG, Holland N, Giesser B, LaRocca N, Madonna M and Scheinberg LC.
Multiple Sclerosis bladder: Studies and care. (1984)Annals of the New York Academy of
Sciences, 436:328-346.
3.Giesser B. Multiple Sclerosis: Current concepts in management. (1985) Drugs 29:88-95.
4.Giesser B. Evoked potentials as outcome measures in Multiple Sclerosis. (1993)
Journal of Neurologic Rehabilitation, 7:99-104
5.Aisen M, Rosen M, Dobkin B, Selzer M, Laven L, Wessell T, Giesser B, Sparr S
Lennihan L. Position paper: ASNR Scientific Issues Committee. (1996) Journal of Neurologic Rehabilitation, 10:1-7
6.Whitacre, CC, Reingold, SC, O’Looney, P and the Task Force on Gender, MS, and Autoimmunity. (1999). Science 283 1277-1278
7. Giesser B. Gender Issues in MS. (2002) The Neurologist 8 (6) 351-356
8. Giesser B. Reproductive issues in persons with MS. (2004) Del. J. of Med. 76(3) 125-8
9. Giesser, B. Multiple Sclerosis: A review and update. ( 2006) Family Practice Recertification
28(1) 47-55
10. Giesser, B. Exercise Training in persons with MS. ( Dec. 2007) US Neurological Disease
Vol. ll pp.37-39
11. Ford, C, Halper J, Coyle P, Fox E, Giesser B, et al. Therapeutic decision making in MS:
Best practice algorithms for the MS care practitioner. (Sept.2014) Int. J. of MS Care. 16
(suppl.5)
12. Giesser B. Exercise in the management of persons with MS. (2015)Ther. Adv in
Neurologic Disease 8(3) 123-130
EDITORIALS
Attarian H, Brandes J, Dafer R, Gerard E & Giesser B. Sex differences in the Study of
Neurological Illnesses. ( 2015) In: Behavioral Neurology Vol. 2015 ID 676531
PAPERS IN PREPARATION (RESEARCH COMPLETED)
NONE
ABSTRACTS
1.Giesser B, Kurtzberg D, Arezzo JC, Vaughan HG, Aisen MA, Smith C, Scheinberg LC.
Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of Multiple Sclerosis. Neurology 36(1):284 (Presented at the 38th Annual Meeting of the
American Academy of Neurology, New Orleans, LA., April 1986.
Page 12
Revised, March 16,2016
13
2.Giesser B, Schroeder MM, LaRocca N, Kurtzberg D, Ritter W, Vaughan HG, Scheinberg L.
Cognitive event-related potentials in Multiple Sclerosis patients. Annals of Neurology 24:161
(Presented at the 113th Annual Meeting of the ANA, Philadelphia, PA .1988),
3.Giesser B, Cross A, Halper J, Pulier M, Aisen M, Holland N, Johnson B. Multiple Sclerosis
symptoms fluctuate during the menstrual cycle, Neurology 40(1):141. (Presented at the 42nd
Annual Meeting of the American Academy of Neurology, Miami Beach, Fl, May 1990)
4.Giesser B, Palechka J, Little S, Jarvis J. Laterality of stroke does not predict patterns of
dysphagia. Neurology 43(2):259. (Presented at the 45th Annual Meeting of the American
Academy of Neurology, New York, April 1993). 5.Giesser B, Ellis S, Bergen R. SYNAPSE: Interactive software for the neurology student clerkship. Neurology 48(3):A70. (Presented at the 49th Annual Meeting of the American
Academy of Neurology, Boston, April 1997).
6.Giesser B, Bergen R, Akporiaye E. “Clinical status in MS does not change with the
menstrual cycle.”(Presented at the 9th Ann. Meeting of European Neurologic.Soc. Milan,Italy, June
1999)
7. Coyle PK, Christie S, Fodor P, Fuchs K, Giesser B, Gutierrez A, Lynn J, Weinstock-
Guttman B, Pardo L. MS gender issues: Clinical Practices of women neurologists. Multiple Sclerosis 8
Suppl.1 ( Presented at the 7th Annual ACTRIMS-ECTRIMS Meeting, Baltimore September, 2002)
8. Giesser B, Beres-Jones J, Budovitch A, Herlihy, E Harkema S. Locomotor training using
body weight support on a treadmill in persons with MS. Neurology 64 ( Suppl 1) A355
( Presented at 57th annual meeting of the AAN, Miami Beach, April 2005)
9. Giesser B, Coleman L, Fisher S, Herlihy E, Nonguchi S, Nowack D, Roberts C, Nowack K.
Living well: Promoting positive health behaviors in persons with MS. ( Presented at the annual
meeting of the ASNR/ACRM Chicago, September, 2005)
10. Sicotte N, Giesser B, Steiner B, Klutch R, Tandon V, Drain A et al. A pilot study of
testosterone for men with relapsing remitting MS. Neurology 66 ( Suppl.2) A 30 ( Presented at
58th annual meeting of the AAN, San Diego April 2006)
11. Cardinal KS, Giesser B, Klutch R, Drain A, Sicotte N. A longitudinal fMRI study of PASAT
performance in healthy controls. (Presented at Society for Human Brain Mapping meeting Florence, Italy (June, 2006)
12. Sicotte N, Kern K, Giesser B, Arshanapalli A, Burggren A, Bookheimer S. Regional
hippocampal atrophy in relapsing remitting and secondary progressive MS.(presented at the 59th Annual meeting of the AAN Boston, April 2007)
13. Sicotte, N. L. Kern, K. Giesser, B. S. Schultz, A Montag, M Vinters, H. V. Bookheimer, S.
Y. Hippocampal abnormalities in multiple sclerosis: imaging and histopathological findings. 23rd Annual ECTRIMS Conference, Prague, Czech Republic. ( Sep’t. 2007)
14. Sicotte NL, Kern K, Shi, Y, Arshanapalli A, Montag M, Giesser B, Toga A, Bookheimer S.
Structural & functional hippocampal changes in MS. Neurology 70 (suppl.1) A431 (60th Annual
meeting of the AAN Chicago April 2008)
15.Kern,K, Ekstrom A, Suthana N, Giesser B, Montag M, Arshanapali A, Bookheimer, S,
Sicotte N. Altered fMRI activity in hippocampal subregions during verbal learning in MS. Mult.Scl. 14 S6 ( Presented @ACTRIMS/ECTRIMS Montreal, Sep’t. 2008)
Page 13
Revised, March 16,2016
14
16.Sicotte N, Yonggang Y, Kern K, Giesser B, Montag M, Arshanapali, A, Toga A.
Three dimensional surface mapping of subregional hippocampal atrophy in MS:correlation with clinical variables. Mult. Scl. 14 S220 ( Presented @ACTRIMS/ECTRIMS Montreal, Sep’t. 2008)
17. Giesser B, Herlihy E, Plummer-Damato P, West M, Thomas S, Budovitch A, Pokras N,
Guttry M, Regnaux JP, Voskuhl R, Gold S, Dobkin B. Locomotor training may improve cognitive performance in persons with Multiple Sclerosis. Neurology 72(suppl.3) A405(61st
AAN Annual meeting Seattle, April 2009)
18. Kern K, Sarcona J, Giesser B, Montag M, Arshanapalli A, Clark K, Sicotte N. Diffusion
tensor imaging of the corticospinal tracts in early RR MS: correlation of diffusion parameters with motor function. Neurology 72(suppl.3) A140 (61st AAN Annual meeting Seattle, April 2009)
19.Kern K, Momen E, Clark K, Giesser B, Montag M, Arshanapalli A, Shi Y, Sicotte N.
Splenium of the corpus callosum affected in early RRMS: Changes detected with diffusion tensor imaging and thickness measures. Neurology 72(Suppl.3) A 143 (61st AAN Annual
meeting Seattle, April 2009)
20. Gold S, Kern K, Montag M, O’Connor MF, Giesser B, Sicotte N. Flatter diurnal cortisol
slope is associated with regional hippocampal atrophy & depressive symptoms in MS. (ACTRIMS,Atlanta June 2009)
21. Kern K, Bamberg A, Montag M,Giesser B, Sicotte N. Evidence of subtle hippocampal
dysfunction is detectable in R/R MS. ( ACTRIMS Atlanta, June 2009)
22. Sicotte N, Kern K, Sarcona J, Montag M, Giesser B. Ipsilateral motor cortex activity in
RRMS: Compensation or not. Neurology 74 (suppl.2) A364 (62nd annual meeting AAN
Toronto, April, 2010)
23. Chang, E, Crandall, C, Giesser, B, Haselkorn J, Bever C, Shekelle P, Hays R, Vickrey B.
Quality indicators for MS. Neurology 74 ( suppl. 2) A 313 ( 62nd annual meeting AAN, Toronto,
April 2010)
24. Gold S, Kern K, O’Connor, MF, Montag M, Kim A, Giesser B, Sicotte N. Subregional
hippocampal atrophy is linked to depressive symptoms in MS. Neurology 74 ( suppl 2).
A 507(62nd annual meeting AAN Toronto, April, 2010)
25. Sicotte N, Kern K, Montag M, Kim A, Horsfall J, Giesser B. Thalamic subregions
associated with cognitive impairment in MS. ( 15th annual ECTRIMS meeting, Gotesberg, Sweden Oct. 2010)
26. Giesser B, Herlihy E, Plummer D’Amato P, West M, Budovitch A, Pokras N,et al.
Randomized controlled trial of robotic locomotor training in person with MS. ( 5th triennial ECTRIMS/ACTRIMS meeting Amsterdam, The Netherlands ( Oct., 2011)
27. Sicotte N, Shi Y, Montag M, Giesser B, Toga A. Localizing clinically relevant diffusion
changes in the corpus callosum in MS: application of a new imaging metric. (64th annual AAN meeting New Orleans, April 2012)
28. Kurth, F., Luders, E., Sicotte, N., Gaser, C., Giesser, B., Swerdloff, R.S., Montag, M.,
Voskuhl, R.R. and Mackenzie-Graham, A. Restoration of gray matter loss induced by
testosterone treatment of men with multiple sclerosis. (Society for Neuroscience, November,
San Diego, CA 2013.)
29. Voskuhl R, Wang H, Wu T.C., Sicotte N, Bates A, Beaver G,Corboy J, Cross A, Dhib-
Jalbut S, Ford C, Giesser B , Dina Jacobs, Sharon Lynch, Andrew Pachner, Michael Racke,
John Ratchford, Anthony Reder, John Rose, Dean Wingerchuk, Margaret Burnett, Chi Hong
Tseng, Robert Elashoff. A Combination Trial of Estriol Plus Glatimer Acetate in Relapsing-
Remitting Multiple Sclerosis. (66th annual meeting AAN, Philadelphia April 2014)
Page 14
Revised, March 16,2016
15
30. Dorsch A, Thomas S, Giesser B. “The Effect of Cooling on Community-Based Walking in
Heat-Sensitive Patients with Multiple Sclerosis: Findings From the Use of Wireless Activity
Monitoring” (67th annual meeting AAN, Wash DC, April 2015)
31. Cahill C, Workgroup members, Waubant E, Burnett M, Carter J, Giesser B, et al. “An
Analysis of How Neurology Trainees select fellowships” ( 68th annual meeting AAN Vancouver,
BC April 2016)
Web-Based Publications
“Sick & Tired: Diagnosing and Treating Fatigue in Multiple Sclerosis.” Neurolearn (American
Academy of Neurology, July 2012,revised, September, 2015)
Page 15